Auditory Changes in Occupational Health Associated With Metabolic Diseases in Adult Workers.

Francine Varlete Leopoldina Barcelos, Karina Mary de Paiva, Marco José Machado, Patrícia Haas
Author Information
  1. Francine Varlete Leopoldina Barcelos: Occupational Speech Therapist from the Conselho Federal de Fonoaudiologia (CFFa), Federal University of Santa Catarina UFSC, Florianopolis, Brazil (FVLB).
  2. Karina Mary de Paiva: Department of Speech Therapy, Federal University of Santa Catarina - UFSC, Florianopolis, Brazil (KMP).
  3. Marco José Machado: Federal University of Santa Catarina - UFSC, Florianopolis, Brazil (MJM).
  4. Patrícia Haas: Federal University of Fronteira Sul - UFSC, Chapecó, Brazil (PH). ORCID

Abstract

INTRODUCTION: The most common hearing losses in the population are associated with genetic conditions, use of ototoxic substances or medications, infectious diseases, metabolic diseases and chronic ear diseases and the association of exposure to occupational risks or the natural aging process.
OBJECTIVE: Verify the association between hearing loss in workers and metabolic diseases.
METHOD: Retrospective cross-sectional study with analysis of secondary data of subjects exposed to occupational noise and undergoing drug treatment for metabolic disease, attended in two occupational health clinics (C1 and C2) from January 2020 to December 2022, considering the data of reference examinations from the year 2005.
RESULTS: Of the n = 97 subjects evaluated, 73.20% were male, exposed to occupational noise (64.90%), with medication use for treating cardiovascular diseases (89.70%). The most recurrent auditory complaint was tinnitus (28.90%), n = 53 subjects presented sensorineural hearing loss with a statistical association between the decline of hearing loss and medications used for metabolic and hormonal regulation.
CONCLUSION: Here was a higher frequency in the use of medications for treating cardiovascular diseases with a risk of triggering or worsening hearing loss in these subjects and greater impairment and decline of hearing thresholds were observed in the results of C2.

Keywords

References

  1. ORL J Otorhinolaryngol Relat Spec. 2022;84(3):238-246 [PMID: 34515191]
  2. Int J Environ Res Public Health. 2022 Feb 01;19(3): [PMID: 35162712]
  3. Rev Bras Epidemiol. 2015 Jul-Sep;18(3):679-90 [PMID: 26247191]
  4. Codas. 2020 Feb 03;32(2):e20180259 [PMID: 32022100]
  5. J Clin Med. 2023 Mar 17;12(6): [PMID: 36983347]
  6. Ear Hear. 2014 May-Jun;35(3):e44-51 [PMID: 24518430]
  7. Cureus. 2021 Sep 21;13(9):e18156 [PMID: 34692350]
  8. Codas. 2018;30(2):e20170127 [PMID: 29791615]
  9. Int J Occup Med Environ Health. 2020 Oct 20;33(6):841-848 [PMID: 32994587]
  10. Indian J Otolaryngol Head Neck Surg. 2022 Aug;74(Suppl 1):532-540 [PMID: 36032913]
  11. Front Aging Neurosci. 2022 Jul 29;14:930105 [PMID: 35966796]
  12. Rev Bras Epidemiol. 2019 Dec 05;22:e190063 [PMID: 31826118]
  13. Clin Interv Aging. 2020 Dec 30;15:2453-2467 [PMID: 33408469]
  14. Cien Saude Colet. 2023 May;28(5):1563-1573 [PMID: 37194887]
  15. Int J Audiol. 2015 Feb;54 Suppl 1:S30-6 [PMID: 25549168]
  16. Cad Saude Publica. 2021 Oct 08;37(10):e00202220 [PMID: 34644758]
  17. Stat Med. 2022 Nov 20;41(26):5335-5348 [PMID: 36125070]
  18. BMJ Open. 2019 May 1;9(4):e022440 [PMID: 31048419]
  19. PLoS One. 2015 Aug 06;10(8):e0134388 [PMID: 26247614]
  20. Sci Rep. 2023 Jan 30;13(1):1642 [PMID: 36717643]
  21. Braz J Otorhinolaryngol. 2020 Nov - Dec;86(6):665-666 [PMID: 32417151]
  22. Br J Hosp Med (Lond). 2019 Sep 2;80(9):525-529 [PMID: 31498679]
  23. Cad Saude Publica. 2014 Nov;30(11):2344-2356 [PMID: 25493988]
  24. J Biotechnol. 2020 Apr 10;313:1-10 [PMID: 32151643]
  25. Occup Environ Med. 2019 May;76(5):341-348 [PMID: 30683670]
  26. Hypertens Res. 2022 Jan;45(1):172-174 [PMID: 34707218]
  27. Indian J Community Med. 2022 Apr-Jun;47(2):166-171 [PMID: 36034244]
  28. Cien Saude Colet. 2022 Apr;27(4):1567-1580 [PMID: 35475836]
  29. Environ Health Prev Med. 2020 Oct 31;25(1):65 [PMID: 33129267]
  30. Int J Environ Res Public Health. 2023 Feb 08;20(4): [PMID: 36833630]
  31. PLoS One. 2021 Jul 30;16(7):e0255356 [PMID: 34329348]
  32. BMJ Open. 2019 Apr 4;9(4):e027152 [PMID: 30948611]
  33. J Nutr. 2018 Jun 1;148(6):944-951 [PMID: 29757402]
  34. Braz J Otorhinolaryngol. 2018 Nov - Dec;84(6):754-763 [PMID: 29030131]
  35. Int J Audiol. 2020 Feb;59(sup1):S20-S30 [PMID: 31846396]
  36. Lancet. 2018 Nov 10;392(10159):1923-1994 [PMID: 30496105]
  37. PLoS One. 2018 Mar 29;13(3):e0195227 [PMID: 29596478]
  38. Ear Hear. 2021 Nov-Dec 01;42(6):1472-1484 [PMID: 34010248]
  39. Lancet Reg Health Eur. 2021 Nov 04;12:100250 [PMID: 34950918]

Word Cloud

Created with Highcharts 10.0.0hearingdiseasesmetabolicoccupationallosssubjectsusemedicationsassociationnoisedataexposedhealthC2n=90%treatingcardiovasculardeclineINTRODUCTION:commonlossespopulationassociatedgeneticconditionsototoxicsubstancesinfectiouschronicearexposurerisksnaturalagingprocessOBJECTIVE:VerifyworkersMETHOD:Retrospectivecross-sectionalstudyanalysissecondaryundergoingdrugtreatmentdiseaseattendedtwoclinicsC1January2020December2022consideringreferenceexaminationsyear2005RESULTS:97evaluated7320%male64medication8970%recurrentauditorycomplainttinnitus2853presentedsensorineuralstatisticalusedhormonalregulationCONCLUSION:higherfrequencyrisktriggeringworseninggreaterimpairmentthresholdsobservedresultsAuditoryChangesOccupationalHealthAssociatedMetabolicDiseasesAdultWorkersadultsyndromenoise-inducedprimarycare

Similar Articles

Cited By